Anti-Infective Agents Completed Phase 4 Trials for Cefazolin (DB01327)

IndicationStatusPhase
DBCOND0046346 (Anti-Infective Agents)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01244698Postoperative Antibiotic Requirements Following Immediate Breast ReconstructionTreatment